AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34210333 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care including medical check-up results and lifestyle recommendations)
Number of subjects: 4484
Study 32898170 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular stimulation with a 12-week rehabilitation program (n = 25)
Number of subjects: 52
Study 32898170 — intervention group
Group type: COMPARATOR
Intervention: Sham intramuscular stimulation with a 12-week rehabilitation program (n = 19)
Number of subjects: 52
Study 32898170 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation program alone (control group) (n = 8)
Number of subjects: 52
Study 35046201 — intervention group
Group type: EXPERIMENTAL
Intervention: I-gel
Number of subjects: 64
Study 35046201 — intervention group
Group type: COMPARATOR
Intervention: LMA Protector
Number of subjects: 64
Study 34217654 — intervention group
Group type: EXPERIMENTAL
Intervention: Class I recommendation for ICD implantation
Number of subjects: 188
Study 34217654 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEFs ≤35%
Number of subjects: 188
Study 34217654 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEFs >35%
Number of subjects: 188
Study 34217654 — intervention group
Group type: EXPERIMENTAL
Intervention: Late gadolinium enhancement
Number of subjects: 188
Study 36355382 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based screening using combined targeted and standard biopsies
Number of subjects: 1532
Study 36355382 — intervention group
Group type: COMPARATOR
Intervention: Standard biopsies alone
Number of subjects: 1532
Study 36355382 — intervention group
Group type: COMPARATOR
Intervention: No screening
Number of subjects: 1532
Study 34499574 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant rabies G protein vaccine
Number of subjects: 800
Study 34499574 — intervention group
Group type: COMPARATOR
Intervention: Reference vaccine (five-dose WHO prequalified vaccine)
Number of subjects: 800
Study 32246050 — intervention group
Group type: EXPERIMENTAL
Intervention: Anemia prevalence
Number of subjects: 1415
Study 32246050 — intervention group
Group type: EXPERIMENTAL
Intervention: Anemia prevalence by gender
Number of subjects: 1415
Study 32246050 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean hemoglobin levels
Number of subjects: 1415
Study 32246050 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of anemia severity
Number of subjects: 1415
Study 32246050 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with anemia
Number of subjects: 1415
Study 32744902 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretion above 25 mL (drainage longer than 24 hours)
Number of subjects: 205
Study 32744902 — intervention group
Group type: COMPARATOR
Intervention: Secretion below 25 mL (drainage less than 24 hours)
Number of subjects: 205
Study 32744902 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall risk of postoperative infection
Number of subjects: 205
Study 35868138 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (lavender, eucalyptus, or rose oil)
Number of subjects: 120
Study 35868138 — intervention group
Group type: EXPERIMENTAL
Intervention: Su Jok (using buckwheat seed)
Number of subjects: 120
Study 35868138 — intervention group
Group type: EXPERIMENTAL
Intervention: Su Jok and Aromatherapy (combined)
Number of subjects: 120
Study 35868138 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 120
Study 33770483 — intervention group
Group type: COMPARATOR
Intervention: ABVD group
Number of subjects: 1686
Study 33770483 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 + 2 group
Number of subjects: 1686
Study 33770483 — intervention group
Group type: EXPERIMENTAL
Intervention: non-randomised 2 + 2 group
Number of subjects: 1686
Study 35564533 — intervention group
Group type: EXPERIMENTAL
Intervention: Air purifier device (professional XXl inn‐561 innoliving) with HEPA 14 filter
Number of subjects: 80
Study 35564533 — intervention group
Group type: COMPARATOR
Intervention: Control Group (without filtering device)
Number of subjects: 80
Study 34305584 — intervention group
Group type: EXPERIMENTAL
Intervention: Elaeagnus angustifolia (15 g of the whole fruit powder)
Number of subjects: 58
Study 34305584 — intervention group
Group type: COMPARATOR
Intervention: Placebo (7.5 g isomalt + 7.5 g cornstarch)
Number of subjects: 58
Study 34086524 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Number of subjects: 30
Study 34086524 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching exercise
Number of subjects: 30
Study 34086524 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of kinesiotaping and stretching
Number of subjects: 30
Study 33030304 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat (85%), 15% protein, essentially carbohydrate-free (CHO-free) diet for 72 hours
Number of subjects: 7
Study 33030304 — intervention group
Group type: COMPARATOR
Intervention: Standard mixed (control) diet (30% fat: 15% protein: 55% carbohydrate)
Number of subjects: 7
Study 33030304 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting for 72 hours
Number of subjects: 7
Study 35200566 — intervention group
Group type: EXPERIMENTAL
Intervention: TEMPO (dyadic, web-based psychosocial and physical activity self-management program)
Number of subjects: 49
Study 35200566 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 49
Study 32925909 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-for-performance (P4P) scheme for LARC advice
Number of subjects: 3281667
Study 35791905 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane-based anesthesia (Group D)
Number of subjects: 73
Study 35791905 — intervention group
Group type: COMPARATOR
Intervention: Propofol-based anesthesia (Group P)
Number of subjects: 73
Study 33705612 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SMWLM + PINS
Number of subjects: 60
Study 33705612 — intervention group
Group type: COMPARATOR
Intervention: SMWLM
Number of subjects: 60
Study 33705612 — intervention group
Group type: COMPARATOR
Intervention: PINS
Number of subjects: 60
Study 35170783 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg administered every night for 24 weeks
Number of subjects: 92
Study 35170783 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered every night for 24 weeks
Number of subjects: 92
Study 34369908 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg twice a day + Lamivudine 150 mg twice a day + Zidovudine 300 mg twice a day
Number of subjects: 408
Study 34369908 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz 600 mg four times a day + Lamivudine 150 mg twice a day + Zidovudine 300 mg twice a day
Number of subjects: 408
Study 34369908 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (Raltegravir and Efavirenz)
Number of subjects: 408
Study 32727302 — intervention group
Group type: EXPERIMENTAL
Intervention: ICT group
Number of subjects: 532
Study 32727302 — intervention group
Group type: COMPARATOR
Intervention: no-ICT group
Number of subjects: 532
Study 32727302 — intervention group
Group type: EXPERIMENTAL
Intervention: highest utilization tertile
Number of subjects: 532
Study 34253086 — intervention group
Group type: EXPERIMENTAL
Intervention: Gossypium mustelinum introgression line IL9
Number of subjects: 2
Study 34253086 — intervention group
Group type: COMPARATOR
Intervention: Recurrent parent PD94042
Number of subjects: 2
Study 32629079 — intervention group
Group type: EXPERIMENTAL
Intervention: Atlas-based ABM segmentation
Number of subjects: 176
Study 32629079 — intervention group
Group type: COMPARATOR
Intervention: Custom ABM segmentation
Number of subjects: 176
Study 34730000 — intervention group
Group type: EXPERIMENTAL
Intervention: COMPASS‐TC (Comprehensive Post‐Acute Stroke Services Transitional Care)
Number of subjects: 2262
Study 34730000 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 2262
Study 34598676 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg Trimetazidine (TMZ) 12 hours before surgery
Number of subjects: 0
Study 34598676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32093778 — intervention group
Group type: EXPERIMENTAL
Intervention: Active case-finding (ACF) using a seed-and-recruit model
Number of subjects: 8
Study 32093778 — intervention group
Group type: EXPERIMENTAL
Intervention: Active case-finding (ACF) targeting household and neighborhood contacts
Number of subjects: 8
Study 32093778 — intervention group
Group type: EXPERIMENTAL
Intervention: Active case-finding (ACF) targeting persons aged ≥ 55 years using mobile screening units
Number of subjects: 8
Study 32093778 — intervention group
Group type: COMPARATOR
Intervention: Passive case finding (PCF)
Number of subjects: 8
Study 32093778 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (ACF and PCF)
Number of subjects: 8
Study 35636232 — intervention group
Group type: EXPERIMENTAL
Intervention: MI training (six-months training in Motivational Interviewing)
Number of subjects: 36
Study 32102086 — intervention group
Group type: EXPERIMENTAL
Intervention: Fezolinetant 15, 30, 60, 90 mg BID or 30, 60, 120 mg QD
Number of subjects: 352
Study 32102086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study 36243831 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded exercise test (GXT)
Number of subjects: 10
Study 36243831 — intervention group
Group type: COMPARATOR
Intervention: Submaximal verification bout
Number of subjects: 10
Study 34373282 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu‐PSMA‐617
Number of subjects: 15
Study 34373282 — intervention group
Group type: COMPARATOR
Intervention: Cabazitaxel chemotherapy
Number of subjects: 15
Study 35676218 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week music-based neurological rehabilitation (MBNR)
Number of subjects: 40
Study 34364265 — intervention group
Group type: EXPERIMENTAL
Intervention: Yacon flour (25 g daily)
Number of subjects: 26
Study 34364265 — intervention group
Group type: COMPARATOR
Intervention: Control (no yacon flour)
Number of subjects: 26
Study 34364265 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (yacon flour and control)
Number of subjects: 26
Study 80244778 — intervention group
Group type: EXPERIMENTAL
Intervention: Tar/zinc pyrithione shampoo
Number of subjects: 70
Study 80244778 — intervention group
Group type: COMPARATOR
Intervention: Placebo shampoo
Number of subjects: 70
Study 35288097 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis (AFO) for 6 weeks
Number of subjects: 20
Study 35288097 — intervention group
Group type: EXPERIMENTAL
Intervention: Laterally wedged insole (LWI) for 6 weeks
Number of subjects: 20
Study 35333373 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND+ intervention (with sit-stand workstation)
Number of subjects: 630
Study 35333373 — intervention group
Group type: COMPARATOR
Intervention: MOVE+ intervention (without sit-stand workstation)
Number of subjects: 630
Study 35333373 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 630
Study 34285360 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric (NG) tube insertion
Number of subjects: 50
Study 34285360 — intervention group
Group type: COMPARATOR
Intervention: Orogastric (OG) tube insertion
Number of subjects: 50
Study 34634757 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention to reduce sedentary behaviour, details on dosage and duration not specified.
Number of subjects: 0
Study 34634757 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities implemented and adapted over 6 months, details on specific activities not specified.
Number of subjects: 0
Study 37962288 — intervention group
Group type: EXPERIMENTAL
Intervention: PASCAL
Number of subjects: 300
Study 37962288 — intervention group
Group type: COMPARATOR
Intervention: MitraClip
Number of subjects: 300
Study 37962288 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300
Study 34106974 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving skills intervention delivered through 6 monthly sessions
Number of subjects: 64
Study 33151154 — intervention group
Group type: EXPERIMENTAL
Intervention: My Diabetes Coach (MDC) program
Number of subjects: 187
Study 33151154 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 187
Study 35460239 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Yoga
Number of subjects: 138
Study 35460239 — intervention group
Group type: COMPARATOR
Intervention: Conventional Stretching Exercises
Number of subjects: 138
Study 33400348 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiroxostat 40–160 mg/day
Number of subjects: 0
Study 33400348 — intervention group
Group type: COMPARATOR
Intervention: Febuxostat 10–60 mg/day
Number of subjects: 0
Study 34609671 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoexfoliation syndrome (PXS) group
Number of subjects: 81
Study 34609671 — intervention group
Group type: COMPARATOR
Intervention: Non-PXS group
Number of subjects: 81
Study 616172822 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem-retard
Number of subjects: 67
Study 616172822 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine (Coraxan)
Number of subjects: 67
Study 33509845 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-loaded bone cement (ALBC)
Number of subjects: 9172
Study 33509845 — intervention group
Group type: COMPARATOR
Intervention: Plain bone cement
Number of subjects: 9172
Study 32253081 — intervention group
Group type: EXPERIMENTAL
Intervention: Split x-jaw planning technique
Number of subjects: 20
Study 32253081 — intervention group
Group type: COMPARATOR
Intervention: Open x-jaw planning technique
Number of subjects: 20
Study 32253081 — intervention group
Group type: COMPARATOR
Intervention: Limited x-jaw planning technique
Number of subjects: 20
Study 32253081 — intervention group
Group type: COMPARATOR
Intervention: Split and open techniques
Number of subjects: 20
Study 35679047 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex PCR point‐of‐care testing for respiratory pathogens (18 respiratory viruses and 3 bacteria, results ready within 70 minutes)
Number of subjects: 1243
Study 35679047 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 1243
Study 35679047 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex PCR point‐of‐care testing for respiratory pathogens
Number of subjects: 1243
Study 33180331 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving skill program (10 classroom sessions of 1 hour and 10 on-road sessions of 50 minutes)
Number of subjects: 159
Study 33180331 — intervention group
Group type: COMPARATOR
Intervention: Control group (one education class about safe driving)
Number of subjects: 159
Study 34629006 — intervention group
Group type: EXPERIMENTAL
Intervention: word-problem intervention (n = 56)
Number of subjects: 76
Study 34629006 — intervention group
Group type: COMPARATOR
Intervention: business-as-usual comparison (n = 20)
Number of subjects: 76
Study 33221788 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation program (8-week duration)
Number of subjects: 80
Study 33221788 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment during the same period)
Number of subjects: 80
Study 37676426 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDRS
Number of subjects: 32
Study 34303445 — intervention group
Group type: EXPERIMENTAL
Intervention: Organization intervention
Number of subjects: 148
Study 34303445 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment conditions
Number of subjects: 148
Study 34303445 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 148
Study 32538291 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6 intermediate metabolizers (n = 6)
Number of subjects: 24
Study 32538291 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2B6 G516T T/T (n = 2)
Number of subjects: 24
Study 32538291 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal and ultrarapid metabolizers)
Number of subjects: 24
Study 32538291 — intervention group
Group type: EXPERIMENTAL
Intervention: All volunteers
Number of subjects: 24
Study 35874579 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostrum (C)
Number of subjects: 96
Study 35874579 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 96
Study 33500267 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsiflexion group (group D)
Number of subjects: 120
Study 33500267 — intervention group
Group type: COMPARATOR
Intervention: Neutral group (group N)
Number of subjects: 120
Study 34342742 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-informed, online HIV prevention intervention
Number of subjects: 154
Study 34342742 — intervention group
Group type: COMPARATOR
Intervention: Existing HIV websites (control group)
Number of subjects: 154
Study 34081649 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation by a low vision therapist using video conferencing
Number of subjects: 57
Study 34081649 — intervention group
Group type: COMPARATOR
Intervention: At home self-training provided by the device manufacturer
Number of subjects: 57
Study 36120805 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma (CAP) technology, treated biweekly for five sessions
Number of subjects: 18
Study 36120805 — intervention group
Group type: COMPARATOR
Intervention: Untreated side (control)
Number of subjects: 18
Study 34399847 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT‐VR (Cognitive Behavioural Therapy and Vestibular Rehabilitation)
Number of subjects: 40
Study 34399847 — intervention group
Group type: COMPARATOR
Intervention: VR only (Vestibular Rehabilitation)
Number of subjects: 40
Study 33605575 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 mins)
Number of subjects: 20
Study 33605575 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (control)
Number of subjects: 20
Study 34611132 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline level of Fetuin-B
Number of subjects: 143
Study 36179772 — intervention group
Group type: EXPERIMENTAL
Intervention: Good adherence to oral anticoagulants (OACs) defined as proportion of days covered (PDC) >80%
Number of subjects: 778
Study 32020765 — intervention group
Group type: EXPERIMENTAL
Intervention: DACC-coated dressings
Number of subjects: 246
Study 32020765 — intervention group
Group type: COMPARATOR
Intervention: Alginate dressings
Number of subjects: 246
Study 35016403 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing based on the Roy adaptation model
Number of subjects: 120
Study 35016403 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing measures
Number of subjects: 120
Study 32886138 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquabeam® system
Number of subjects: 0
Study 32886138 — intervention group
Group type: COMPARATOR
Intervention: Prostate artery embolization (PAE)
Number of subjects: 0
Study 32886138 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 0
Study 36195934 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Coherence Exercise (HCE)
Number of subjects: 84
Study 36195934 — intervention group
Group type: COMPARATOR
Intervention: Natural Relaxation (NR)
Number of subjects: 84
Study 36195934 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual TSST
Number of subjects: 84
Study 36195934 — intervention group
Group type: COMPARATOR
Intervention: Real TSST
Number of subjects: 84
Study 34112149 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% cyclopentolate eye drops (two drops, one drop every 5 min)
Number of subjects: 300
Study 34112149 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% tropicamide eye drops (four drops, one drop every 5 min)
Number of subjects: 300
Study 34112149 — intervention group
Group type: COMPARATOR
Intervention: Comparison between cyclopentolate and tropicamide groups
Number of subjects: 300
Study 32792543 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement of hygiene scale
Number of subjects: 196
Study 32792543 — intervention group
Group type: EXPERIMENTAL
Intervention: Boiling raw milk before consumption
Number of subjects: 196
Study 32792543 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban households
Number of subjects: 196
Study 35296534 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab Q4W (100 mg at weeks 0, 4, then every 4 weeks)
Number of subjects: 1120
Study 35296534 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab Q8W (100 mg at weeks 0, 4, then every 8 weeks)
Number of subjects: 1120
Study 35296534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1120
Study 32291275 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment
Number of subjects: 888
Study 32291275 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 888
Study 35331307 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% povidone iodine
Number of subjects: 375
Study 35331307 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine
Number of subjects: 375
Study 35331307 — intervention group
Group type: COMPARATOR
Intervention: No irrigation (control)
Number of subjects: 375
Study 33865507 — intervention group
Group type: EXPERIMENTAL
Intervention: Ravidasvir (200 mg once daily) plus Sofosbuvir (400 mg once daily) for 12 weeks (no cirrhosis) or 24 weeks (with cirrhosis)
Number of subjects: 301
Study 33865507 — intervention group
Group type: EXPERIMENTAL
Intervention: Ravidasvir plus Sofosbuvir
Number of subjects: 301
Study 35466343 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual alignment leveling method
Number of subjects: 36
Study 35466343 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser device leveling method
Number of subjects: 36
Study 35466343 — intervention group
Group type: COMPARATOR
Intervention: Transducer taped to the upper arm
Number of subjects: 36
Study 35466343 — intervention group
Group type: COMPARATOR
Intervention: Transducer next to the upper arm taped to a rolled cloth
Number of subjects: 36
Study 35466343 — intervention group
Group type: COMPARATOR
Intervention: Transducer at the wrist
Number of subjects: 36
Study 35466343 — intervention group
Group type: COMPARATOR
Intervention: Control condition (transducer on intravenous pole)
Number of subjects: 36
Study 34290558 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional PF brace (Study Group, SG)
Number of subjects: 38
Study 34290558 — intervention group
Group type: COMPARATOR
Intervention: Neoprene sleeve for the knee (Control Group, CG)
Number of subjects: 38
Study 35984478 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 185